<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36824451</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury.</ArticleTitle><Pagination><StartPage>1062491</StartPage><MedlinePgn>1062491</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1062491</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2023.1062491</ELocationID><Abstract><AbstractText>The role of hypoxia, vascular endothelial injury, and thrombotic inflammation in worsening COVID-19 symptoms has been generally recognized. Damaged vascular endothelium plays a crucial role in forming <i>in situ</i> thrombosis, pulmonary dysfunction, and hypoxemia. Thrombotic inflammation can further aggravate local vascular endothelial injury and affect ventilation and blood flow ratio. According to the results of many studies, obesity is an independent risk factor for a variety of severe respiratory diseases and contributes to high mechanical ventilation rate, high mortality, and slow recovery in COVID-19 patients. This review will explore the mechanisms by which obesity may aggravate the acute phase of COVID-19 and delay long COVID recovery by affecting hypoxia, vascular endothelial injury, and thrombotic inflammation. A systematic search of PubMed database was conducted for papers published since January 2020, using the medical subject headings of "COVID-19" and "long COVID" combined with the following keywords: "obesity," "thrombosis," "endothelial injury," "inflammation," "hypoxia," "treatment," and "anticoagulation." In patients with obesity, the accumulation of central fat restricts the expansion of alveoli, exacerbating the pulmonary dysfunction caused by SARS-CoV-2 invasion, inflammatory damage, and lung edema. Abnormal fat secretion and immune impairment further aggravate the original tissue damage and inflammation diffusion. Obesity weakens baseline vascular endothelium function leading to an early injury and pre-thrombotic state after infection. Enhanced procoagulant activity and microthrombi promote early obstruction of the vascular. Obesity also prolongs the duration of symptoms and increases the risk of sequelae after hospital discharge. Persistent viral presence, long-term inflammation, microclots, and hypoxia may contribute to the development of persistent symptoms, suggesting that patients with obesity are uniquely susceptible to long COVID. Early interventions, including supplemental oxygen, comprehensive antithrombotic therapy, and anti-inflammatory drugs, show effectiveness in many studies in the prevention of serious hypoxia, thromboembolic events, and systemic inflammation, and are therefore recommended to reduce intensive care unit admission, mortality, and sequelae.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Xiang, Wu, Jing, Novakovic and Shi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Mengqi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiaoming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Haijiao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novakovic</LastName><ForeName>Valerie A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Department of Research, Veterans Affairs Boston Healthcare System and Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jialan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Research, Veterans Affairs Boston Healthcare System and Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">hypoxia</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">thrombotic inflammation</Keyword><Keyword MajorTopicYN="N">vascular endothelial injury</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>2</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36824451</ArticleId><ArticleId IdType="pmc">PMC9941162</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2023.1062491</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sattar N, McInnes IB, McMurray JJV. Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation. (2020) 142:4&#x2013;6. 10.1161/CIRCULATIONAHA.120.047659</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047659</ArticleId><ArticleId IdType="pubmed">32320270</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters U, Suratt BT, Bates JHT, Dixon AE. Beyond BMI: obesity and lung disease. Chest. (2018) 153:702&#x2013;9. 10.1016/j.chest.2017.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2017.07.010</ArticleId><ArticleId IdType="pmc">PMC5989645</ArticleId><ArticleId IdType="pubmed">28728934</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. Obesity and influenza A shedding. JAMA. (2018) 320:1230. 10.1001/jama.2018.13078</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.13078</ArticleId><ArticleId IdType="pubmed">30264101</ArticleId></ArticleIdList></Reference><Reference><Citation>Honce R, Schultz-Cherry S. Impact of obesity on influenza A virus pathogenesis, immune response, and evolution. Front Immunol. (2019) 10:1071. 10.3389/fimmu.2019.01071</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01071</ArticleId><ArticleId IdType="pmc">PMC6523028</ArticleId><ArticleId IdType="pubmed">31134099</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Garg A, Rout A, Lavie CJ. Association of obesity with more critical illness in COVID-19. Mayo Clin Proc. (2020) 95:2040&#x2013;2. 10.1016/j.mayocp.2020.06.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.06.046</ArticleId><ArticleId IdType="pmc">PMC7330549</ArticleId><ArticleId IdType="pubmed">32861346</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Lu Y, Huang YM, Wang M, Ling W, Sui Y, et al. Obesity in patients with COVID-19: a systematic review and meta-analysis. Metabolism. (2020) 113:154378. 10.1016/j.metabol.2020.154378</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154378</ArticleId><ArticleId IdType="pmc">PMC7521361</ArticleId><ArticleId IdType="pubmed">33002478</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamer M, Gale CR, Kivim&#xe4;ki M, Batty GD. Overweight, obesity, and risk of hospitalization for COVID-19: a community-based cohort study of adults in the United Kingdom. Proc Natl Acad Sci U S A. (2020) 117:21011&#x2013;3. 10.1073/pnas.2011086117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2011086117</ArticleId><ArticleId IdType="pmc">PMC7474583</ArticleId><ArticleId IdType="pubmed">32788355</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol. (2020) 16:341&#x2013;2. 10.1038/s41574-020-0364-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-0364-6</ArticleId><ArticleId IdType="pmc">PMC7187148</ArticleId><ArticleId IdType="pubmed">32327737</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendren NS, de Lemos JA, Ayers C, Das SR, Rao A, Carter S, et al. Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19: results from the American heart association COVID-19 cardiovascular disease registry. Circulation. (2021) 143:135&#x2013;44. 10.1161/CIRCULATIONAHA.120.051936</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.051936</ArticleId><ArticleId IdType="pubmed">33200947</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita Y, Maruyama Y, Satokawa H, Nishimoto Y, Tsujino I, Sakashita H, et al. Incidence and clinical features of venous thromboembolism in hospitalized patients with coronavirus disease 2019 (COVID-19) in Japan. Circ J. (2021) 85:2208&#x2013;14. 10.1253/circj.CJ-21-0169</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-21-0169</ArticleId><ArticleId IdType="pubmed">34011824</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. (2022) 28:1706&#x2013;14. 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. (2022) 10:761&#x2013;75. 10.1016/S2213-2600(22)00127-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E, van Willigen HDG, Dijkstra M, Boyd A, Kootstra NA, van den Aardweg JG, et al. Evolution of coronavirus disease 2019 (COVID-19) symptoms during the first 12 months after illness onset. Clin Infect Dis. (2022) 75:e482&#x2013;90. 10.1093/cid/ciab759</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab759</ArticleId><ArticleId IdType="pmc">PMC8522402</ArticleId><ArticleId IdType="pubmed">34473245</ArticleId></ArticleIdList></Reference><Reference><Citation>Caussy C, Pattou F, Wallet F, Simon C, Chalopin S, Telliam C, et al. Prevalence of obesity among adult inpatients with COVID-19 in France. Lancet Diabetes Endocrinol. (2020) 8:562&#x2013;4. 10.1016/S2213-8587(20)30160-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30160-1</ArticleId><ArticleId IdType="pmc">PMC7234780</ArticleId><ArticleId IdType="pubmed">32437642</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y, Lv Y, Zha W, Zhou N, Hong X. Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: a dose-response meta-analysis. Metabolism. (2021) 117:154373. 10.1016/j.metabol.2020.154373</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154373</ArticleId><ArticleId IdType="pmc">PMC7493748</ArticleId><ArticleId IdType="pubmed">32949592</ArticleId></ArticleIdList></Reference><Reference><Citation>Kompaniyets L, Goodman AB, Belay B, Freedman DS, Sucosky MS, Lange SJ, et al. Body mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death - United States, march-december 2020. MMWR Morb Mortal Wkly Rep. (2021) 70:355&#x2013;61. 10.15585/mmwr.mm7010e4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7010e4</ArticleId><ArticleId IdType="pmc">PMC7951819</ArticleId><ArticleId IdType="pubmed">33705371</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. (2020) 108:154262. 10.1016/j.metabol.2020.154262</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154262</ArticleId><ArticleId IdType="pmc">PMC7228874</ArticleId><ArticleId IdType="pubmed">32422233</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli A, Ridolfo AL, Milazzo L, Oreni L, Bernacchia D, Siano M, et al. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study. Pharmacol Res. (2020) 158:104931. 10.1016/j.phrs.2020.104931</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104931</ArticleId><ArticleId IdType="pmc">PMC7242199</ArticleId><ArticleId IdType="pubmed">32446978</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer SL, Sharp WW, Weir EK. Differentiating COVID-19 pneumonia from acute respiratory distress syndrome and high altitude pulmonary edema: therapeutic implications. Circulation. (2020) 142:101&#x2013;4. 10.1161/CIRCULATIONAHA.120.047915</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047915</ArticleId><ArticleId IdType="pmc">PMC7363563</ArticleId><ArticleId IdType="pubmed">32369390</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiuolo J, Mollace R, Gliozzi M, Musolino V, Carresi C, Paone S, et al. The contribution of endothelial dysfunction in systemic injury subsequent to sars-cov-2 infection. Int J Mol Sci. (2020) 21:9309. 10.3390/ijms21239309</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21239309</ArticleId><ArticleId IdType="pmc">PMC7730352</ArticleId><ArticleId IdType="pubmed">33291346</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Covassin N, Fan Z, Singh P, Gao W, Li G, et al. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin Proc. (2020) 95:1138&#x2013;47. 10.1016/j.mayocp.2020.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.04.006</ArticleId><ArticleId IdType="pmc">PMC7151468</ArticleId><ArticleId IdType="pubmed">32376101</ArticleId></ArticleIdList></Reference><Reference><Citation>Attaway AH, Scheraga RG, Bhimraj A, Biehl M, Hatipo&#xf0;lu U. Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ. (2021) 372:n436. 10.1136/bmj.n436</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n436</ArticleId><ArticleId IdType="pubmed">33692022</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. (2020) 7:e575&#x2013;82. 10.1016/S2352-3026(20)30216-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30216-7</ArticleId><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou AG, Keskinidou C, Jahaj E, Gallos P, Dimopoulou I, Kotanidou A, et al. ICU admission levels of endothelial biomarkers as predictors of mortality in critically ill COVID-19 patients. Cells. (2021) 10:186. 10.3390/cells10010186</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10010186</ArticleId><ArticleId IdType="pmc">PMC7832393</ArticleId><ArticleId IdType="pubmed">33477776</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Qin L, Zhang P, Li K, Liang L, Sun J, et al. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight. (2020) 5:e139834. 10.1172/jci.insight.139834</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.139834</ArticleId><ArticleId IdType="pmc">PMC7406242</ArticleId><ArticleId IdType="pubmed">32501293</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. (2020) 130:2620&#x2013;9. 10.1172/JCI137244</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorward DA, Russell CD, Um IH, Elshani M, Armstrong SD, Penrice-Randal R, et al. Tissue-specific immunopathology in fatal COVID-19. Am J Respir Crit Care Med. (2021) 203:192&#x2013;201. 10.1164/rccm.202008-3265OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202008-3265OC</ArticleId><ArticleId IdType="pmc">PMC7874430</ArticleId><ArticleId IdType="pubmed">33217246</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC). Cardiovasc Diabetol. (2022) 21:148. 10.1186/s12933-022-01579-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. Clues to long COVID. Science. (2022) 376:1261&#x2013;5. 10.1126/science.add4297</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.add4297</ArticleId><ArticleId IdType="pubmed">35709281</ArticleId></ArticleIdList></Reference><Reference><Citation>Flint SW, Tahrani AA. COVID-19 and obesity-lack of clarity, guidance, and implications for care. Lancet Diabetes Endocrinol. (2020) 8:474&#x2013;5. 10.1016/S2213-8587(20)30156-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30156-X</ArticleId><ArticleId IdType="pmc">PMC7190298</ArticleId><ArticleId IdType="pubmed">32359411</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Chavolla OY, Bahena-L&#xf3;pez JP, Antonio-Villa NE, Vargas-V&#xe1;zquez A, Gonz&#xe1;lez-D&#xed;az A, M&#xe1;rquez-Salinas A, et al. Predicting mortality due to SARS-CoV-2: a mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico. J Clin Endocrinol Metab. (2020) 105:dgaa346. 10.1210/clinem/dgaa346</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa346</ArticleId><ArticleId IdType="pmc">PMC7313944</ArticleId><ArticleId IdType="pubmed">32474598</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, Duarte-Salles T, Fernandez-Bertolin S, Reyes C, Kostka K, Delmestri A, et al. Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study. Lancet Infect Dis. (2022) 22:1142&#x2013;52. 10.1016/S1473-3099(22)00223-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00223-7</ArticleId><ArticleId IdType="pmc">PMC9106320</ArticleId><ArticleId IdType="pubmed">35576963</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, Fonseca-Rodr&#xed;guez O, Farrington P, Jerndal H, Lundevaller EH, Sund M, et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ. (2022) 377:e069590. 10.1136/bmj-2021-069590</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069590</ArticleId><ArticleId IdType="pmc">PMC8984137</ArticleId><ArticleId IdType="pubmed">35387772</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. (2021) 19:2546&#x2013;53. 10.1111/jth.15490</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauch A, Dupont A, Goutay J, Caplan M, Staessens S, Moussa M, et al. Endotheliopathy is induced by plasma from critically ill patients and associated with organ failure in severe COVID-19. Circulation. (2020) 142:1881&#x2013;4. 10.1161/CIRCULATIONAHA.120.050907</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.050907</ArticleId><ArticleId IdType="pmc">PMC7643783</ArticleId><ArticleId IdType="pubmed">32970476</ArticleId></ArticleIdList></Reference><Reference><Citation>McCafferty C, Van Den Helm S, Letunica N, Attard C, Karlaftis V, Cai T, et al. Increased platelet activation in SARS-CoV-2 infected non-hospitalised children and adults, and their household contacts. Br J Haematol. (2021) 195:90&#x2013;4. 10.1111/bjh.17629</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.17629</ArticleId><ArticleId IdType="pmc">PMC8239564</ArticleId><ArticleId IdType="pubmed">34101171</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevers EM, Williamson PL. Getting to the outer leaflet: physiology of phosphatidylserine exposure at the plasma membrane. Physiol Rev. (2016) 96:605&#x2013;45. 10.1152/physrev.00020.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00020.2015</ArticleId><ArticleId IdType="pubmed">26936867</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie R, Gao C, Li W, Zhu J, Novakovic V, Wang J, et al. Phagocytosis by macrophages and endothelial cells inhibits procoagulant and fibrinolytic activity of acute promyelocytic leukemia cells. Blood. (2012) 119:2325&#x2013;34. 10.1182/blood-2011-06-362186</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-06-362186</ArticleId><ArticleId IdType="pubmed">22138513</ArticleId></ArticleIdList></Reference><Reference><Citation>Rausch L, Lutz K, Schifferer M, Winheim E, Gruber R, Oesterhaus EF, et al. Binding of phosphatidylserine-positive microparticles by PBMCs classifies disease severity in COVID-19 patients. J Extracell Vesicles. (2021) 10:e12173. 10.1002/jev2.12173</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12173</ArticleId><ArticleId IdType="pmc">PMC8636722</ArticleId><ArticleId IdType="pubmed">34854246</ArticleId></ArticleIdList></Reference><Reference><Citation>Langer F, Ruf W. Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation. Thromb Haemost. (2014) 111:590&#x2013;7. 10.1160/TH13-09-0802</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH13-09-0802</ArticleId><ArticleId IdType="pmc">PMC4270292</ArticleId><ArticleId IdType="pubmed">24452853</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. (2020) 324:782&#x2013;93. 10.1001/jama.2020.12839</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. (2021) 93:250&#x2013;6. 10.1002/jmv.26232</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Selva KJ, Chung AW. Insights into how SARS-CoV2 infection induces cytokine storms. Trends Immunol. (2022) 43:417&#x2013;9. 10.1016/j.it.2022.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.04.007</ArticleId><ArticleId IdType="pmc">PMC9077489</ArticleId><ArticleId IdType="pubmed">35537983</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallapaty S. What triggers severe COVID? Infected immune cells hold clues. Nature. (2022) 604:231. 10.1038/d41586-022-00965-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-00965-z</ArticleId><ArticleId IdType="pubmed">35388153</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Ward SE, Townsend L, Karampini E, Elliott S, Conlon N, et al. Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction. J Thromb Haemost. (2021) 20:2429&#x2013;38. 10.1111/jth.15830</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15830</ArticleId><ArticleId IdType="pmc">PMC9349977</ArticleId><ArticleId IdType="pubmed">35875995</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchis-Gomar F, Lavie CJ, Mehra MR, Henry BM, Lippi G. Obesity and outcomes in COVID-19: when an epidemic and pandemic collide. Mayo Clin Proc. (2020) 95:1445&#x2013;53. 10.1016/j.mayocp.2020.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7236707</ArticleId><ArticleId IdType="pubmed">32622449</ArticleId></ArticleIdList></Reference><Reference><Citation>Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med. (2008) 264:224&#x2013;36. 10.1111/j.1365-2796.2008.01981.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2008.01981.x</ArticleId><ArticleId IdType="pmc">PMC7166930</ArticleId><ArticleId IdType="pubmed">18793332</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall RP, Gohlke P, Chambers RC, Howell DC, Bottoms SE, Unger T, et al. Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol. (2004) 286:L156&#x2013;64. 10.1152/ajplung.00313.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00313.2002</ArticleId><ArticleId IdType="pubmed">12754187</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai Y, Kuba K, Penninger JM. The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice. Exp Physiol. (2008) 93:543&#x2013;8. 10.1113/expphysiol.2007.040048</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/expphysiol.2007.040048</ArticleId><ArticleId IdType="pmc">PMC7197898</ArticleId><ArticleId IdType="pubmed">18448662</ArticleId></ArticleIdList></Reference><Reference><Citation>Hess DC, Eldahshan W, Rutkowski E. COVID-19-related stroke. Transl Stroke Res. (2020) 11:322&#x2013;5. 10.1007/s12975-020-00818-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12975-020-00818-9</ArticleId><ArticleId IdType="pmc">PMC7202903</ArticleId><ArticleId IdType="pubmed">32378030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. (2020) 383:120&#x2013;8. 10.1056/NEJMoa2015432</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassir R. Risk of COVID-19 for patients with obesity. Obes Rev. (2020) 21:e13034. 10.1111/obr.13034</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.13034</ArticleId><ArticleId IdType="pmc">PMC7235532</ArticleId><ArticleId IdType="pubmed">32281287</ArticleId></ArticleIdList></Reference><Reference><Citation>Poulain M, Doucet M, Major GC, Drapeau V, S&#xe9;ri&#xe8;s F, Boulet LP, et al. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ. (2006) 174:1293&#x2013;9. 10.1503/cmaj.051299</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.051299</ArticleId><ArticleId IdType="pmc">PMC1435949</ArticleId><ArticleId IdType="pubmed">16636330</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;pin JL, Timsit JF, Tamisier R, Borel JC, L&#xe9;vy P, Jaber S. Prevention and care of respiratory failure in obese patients. Lancet Respir Med. (2016) 4:407&#x2013;18. 10.1016/S2213-2600(16)00054-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)00054-0</ArticleId><ArticleId IdType="pubmed">27304558</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao YM, Xu G, Wang B, Liu BC. Cytokine storm syndrome in coronavirus disease 2019: a narrative review. J Intern Med. (2021) 289:147&#x2013;61. 10.1111/joim.13144</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13144</ArticleId><ArticleId IdType="pmc">PMC7404514</ArticleId><ArticleId IdType="pubmed">32696489</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. (2020) 20:355&#x2013;62. 10.1038/s41577-020-0331-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Dockrell DH, Russell CD, McHugh B, Fraser R. Does autonomous macrophage-driven inflammation promote alveolar damage in COVID-19? Eur Respir J. (2022) 25:2201521. 10.1183/13993003.01521-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01521-2022</ArticleId><ArticleId IdType="pmc">PMC9411729</ArticleId><ArticleId IdType="pubmed">36028257</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues RS, Motta Ribeiro G, Barreto MM, Zin WA, de Toledo-Mendes J, Martins PAG, et al. Increased lung immune metabolic activity in COVID-19 survivors. Clin Nucl Med. (2022) 47:1019&#x2013;25. 10.1097/RLU.0000000000004376</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLU.0000000000004376</ArticleId><ArticleId IdType="pmc">PMC9653065</ArticleId><ArticleId IdType="pubmed">36026599</ArticleId></ArticleIdList></Reference><Reference><Citation>Govender M, Hopkins FR, G&#xf6;ransson R, Svanberg C, Shankar EM, Hjorth M, et al. T cell perturbations persist for at least 6 months following hospitalization for COVID-19. Front Immunol. (2022) 13:931039. 10.3389/fimmu.2022.931039</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.931039</ArticleId><ArticleId IdType="pmc">PMC9393525</ArticleId><ArticleId IdType="pubmed">36003367</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Jones S, &#xd6;sterberg B, Smed-S&#xf6;rensen A. Respiratory and systemic monocytes, dendritic cells, and myeloid-derived suppressor cells in COVID-19: implications for disease severity. J Intern Med. (2022) 293:130&#x2013;43. 10.1111/joim.13559</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13559</ArticleId><ArticleId IdType="pmc">PMC9538918</ArticleId><ArticleId IdType="pubmed">35996885</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivas E, Arismendi E, Agust&#xed; A, Sanchez M, Delgado S, Gistau C, et al. Ventilation/Perfusion distribution abnormalities in morbidly obese subjects before and after bariatric surgery. Chest. (2015) 147:1127&#x2013;34. 10.1378/chest.14-1749</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.14-1749</ArticleId><ArticleId IdType="pubmed">25317652</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y, Hui X, Hoo RLC, Ye D, Chan CYC, Feng T, et al. Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation. J Clin Invest. (2019) 129:834&#x2013;49. 10.1172/JCI123069</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI123069</ArticleId><ArticleId IdType="pmc">PMC6355214</ArticleId><ArticleId IdType="pubmed">30667374</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng T, Lyon CJ, Bergin S, Caligiuri MA, Hsueh WA. Obesity, inflammation, and cancer. Annu Rev Pathol. (2016) 11:421&#x2013;49. 10.1146/annurev-pathol-012615-044359</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-012615-044359</ArticleId><ArticleId IdType="pubmed">27193454</ArticleId></ArticleIdList></Reference><Reference><Citation>Kl&#xf6;ting N, Bl&#xfc;her M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. (2014) 15:277&#x2013;87. 10.1007/s11154-014-9301-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-014-9301-0</ArticleId><ArticleId IdType="pubmed">25344447</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisman DE, Ronner L, Pinotti R, Taylor MD, Sinha P, Calfee CS, et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. (2020) 8:1233&#x2013;44. 10.1016/S2213-2600(20)30404-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30404-5</ArticleId><ArticleId IdType="pmc">PMC7567529</ArticleId><ArticleId IdType="pubmed">33075298</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinney SP, Giustino G, Halperin JL, Mechanick JI, Neibart E, Olin JW, et al. Coronavirus historical perspective, disease mechanisms, and clinical outcomes: JACC focus seminar. J Am Coll Cardiol. (2020) 76:1999&#x2013;2010. 10.1016/j.jacc.2020.08.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.058</ArticleId><ArticleId IdType="pmc">PMC7571970</ArticleId><ArticleId IdType="pubmed">33092736</ArticleId></ArticleIdList></Reference><Reference><Citation>Marazuela M, Giustina A, Puig-Domingo M. Endocrine and metabolic aspects of the COVID-19 pandemic. Rev Endocr Metab Disord. (2020) 21:495&#x2013;507. 10.1007/s11154-020-09569-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-020-09569-2</ArticleId><ArticleId IdType="pmc">PMC7343578</ArticleId><ArticleId IdType="pubmed">32643004</ArticleId></ArticleIdList></Reference><Reference><Citation>McElvaney OJ, McEvoy NL, McElvaney OF, Carroll TP, Murphy MP, Dunlea DM, et al. Characterization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med. (2020) 202:812&#x2013;21. 10.1164/rccm.202005-1583OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202005-1583OC</ArticleId><ArticleId IdType="pmc">PMC7491404</ArticleId><ArticleId IdType="pubmed">32584597</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaikh SR, MacIver NJ, Beck MA. Obesity dysregulates the immune response to influenza infection and vaccination through metabolic and inflammatory mechanisms. Annu Rev Nutr. (2022) 42:67&#x2013;89. 10.1146/annurev-nutr-062320-115937</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-nutr-062320-115937</ArticleId><ArticleId IdType="pmc">PMC10880552</ArticleId><ArticleId IdType="pubmed">35995048</ArticleId></ArticleIdList></Reference><Reference><Citation>Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis. (2006) 6:438&#x2013;46. 10.1016/S1473-3099(06)70523-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(06)70523-0</ArticleId><ArticleId IdType="pubmed">16790384</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation abnormalities and thrombosis in patients infected with SARS-CoV-2 and other pandemic viruses. Arterioscler Thromb Vasc Biol. (2020) 40:2033&#x2013;44. 10.1161/ATVBAHA.120.314514</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.314514</ArticleId><ArticleId IdType="pmc">PMC7447001</ArticleId><ArticleId IdType="pubmed">32657623</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho Y, Shore SA. Obesity, asthma, and the microbiome. Physiology. (2016) 31:108&#x2013;16. 10.1152/physiol.00045.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiol.00045.2015</ArticleId><ArticleId IdType="pmc">PMC4888975</ArticleId><ArticleId IdType="pubmed">26889016</ArticleId></ArticleIdList></Reference><Reference><Citation>Godoy LC, Goligher EC, Lawler PR, Slutsky AS, Zarychanski R. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19. CMAJ. (2020) 192:E1156&#x2013;61. 10.1503/cmaj.201240</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.201240</ArticleId><ArticleId IdType="pmc">PMC7546749</ArticleId><ArticleId IdType="pubmed">32816822</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med. (1996) 2:800&#x2013;3. 10.1038/nm0796-800</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0796-800</ArticleId><ArticleId IdType="pubmed">8673927</ArticleId></ArticleIdList></Reference><Reference><Citation>Balbi C, Burrello J, Bolis S, Lazzarini E, Biemmi V, Pianezzi E, et al. Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 Infection. Ebiomedicine. (2021) 67:103369. 10.1016/j.ebiom.2021.103369</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103369</ArticleId><ArticleId IdType="pmc">PMC8104913</ArticleId><ArticleId IdType="pubmed">33971404</ArticleId></ArticleIdList></Reference><Reference><Citation>Althaus K, Marini I, Zlamal J, Pelzl L, Singh A, H&#xe4;berle H, et al. Antibody-induced procoagulant platelets in severe COVID-19 infection. Blood. (2021) 137:1061&#x2013;71. 10.1182/blood.2020008762</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020008762</ArticleId><ArticleId IdType="pmc">PMC7791311</ArticleId><ArticleId IdType="pubmed">33512415</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza G, Morrow DA. Diagnosis, management, and pathophysiology of arterial and venous thrombosis in COVID-19. JAMA. (2020) 324:2548&#x2013;9. 10.1001/jama.2020.23422</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.23422</ArticleId><ArticleId IdType="pubmed">33226423</ArticleId></ArticleIdList></Reference><Reference><Citation>Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. (2020) 8:782&#x2013;92. 10.1016/S2213-8587(20)30238-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30238-2</ArticleId><ArticleId IdType="pmc">PMC7367664</ArticleId><ArticleId IdType="pubmed">32687793</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. The mystery of the pandemic&#x2019;s &#x2018;happy hypoxia&#x2019;. Science. (2020) 368:455&#x2013;6. 10.1126/science.368.6490.455</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.368.6490.455</ArticleId><ArticleId IdType="pubmed">32355007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruse JM, Magomedov A, Kurreck A, M&#xfc;nch FH, Koerner R, Kamhieh-Milz J, et al. Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis. Crit Care. (2020) 24:676. 10.1186/s13054-020-03401-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03401-8</ArticleId><ArticleId IdType="pmc">PMC7719734</ArticleId><ArticleId IdType="pubmed">33287877</ArticleId></ArticleIdList></Reference><Reference><Citation>Damouche A, Lazure T, Avettand-F&#xe8;no&#xeb;l V, Huot N, Dejucq-Rainsford N, Satie AP, et al. Adipose tissue is a neglected viral reservoir and an inflammatory site during chronic HIV and SIV infection. PLoS Pathog. (2015) 11:e1005153. 10.1371/journal.ppat.1005153</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005153</ArticleId><ArticleId IdType="pmc">PMC4581628</ArticleId><ArticleId IdType="pubmed">26402858</ArticleId></ArticleIdList></Reference><Reference><Citation>Couturier J, Suliburk JW, Brown JM, Luke DJ, Agarwal N, Yu X, et al. Human adipose tissue as a reservoir for memory CD4+ T cells and HIV. AIDS. (2015) 29:667&#x2013;74. 10.1097/QAD.0000000000000599</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000000599</ArticleId><ArticleId IdType="pmc">PMC4389783</ArticleId><ArticleId IdType="pubmed">25849830</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura H, Itamura S, Iwasaki T, Kurata T, Tashiro M. Characterization of human influenza A (H5N1) virus infection in mice: neuro-, pneumo- and adipotropic infection. J Gen Virol. (2000) 81:2503&#x2013;10. 10.1099/0022-1317-81-10-2503</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-81-10-2503</ArticleId><ArticleId IdType="pubmed">10993940</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Col&#xf3;n GJ, Ratnasiri K, Chen H, Jiang S, Zanley E, Rustagi A, et al. SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages. Sci Transl Med. (2022) 14:eabm9151. 10.1126/scitranslmed.abm9151</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abm9151</ArticleId><ArticleId IdType="pmc">PMC9529056</ArticleId><ArticleId IdType="pubmed">36137009</ArticleId></ArticleIdList></Reference><Reference><Citation>Basolo A, Poma AM, Bonuccelli D, Proietti A, Macerola E, Ugolini C, et al. Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response. J Endocrinol Invest. (2022) 45:1021&#x2013;9. 10.1007/s40618-022-01742-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-022-01742-5</ArticleId><ArticleId IdType="pmc">PMC8852916</ArticleId><ArticleId IdType="pubmed">35169984</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Zorita S, Milton-Laskibar I, Garc&#xed;a-Arellano L, Gonz&#xe1;lez M, Portillo MP. An overview of adipose tissue ACE2 modulation by diet and obesity. potential implications in COVID-19 infection and severity. Int J Mol Sci. (2021) 22:7975. 10.3390/ijms22157975</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22157975</ArticleId><ArticleId IdType="pmc">PMC8347022</ArticleId><ArticleId IdType="pubmed">34360741</ArticleId></ArticleIdList></Reference><Reference><Citation>Zickler M, Stanelle-Bertram S, Ehret S, Heinrich F, Lange P, Schaumburg B, et al. Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans. Cell Metab. (2022) 34:1&#x2013;2. 10.1016/j.cmet.2021.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.12.002</ArticleId><ArticleId IdType="pmc">PMC8663969</ArticleId><ArticleId IdType="pubmed">34895500</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiterer M, Rajan M, G&#xf3;mez-Banoy N, Lau JD, Gomez-Escobar LG, Ma L, et al. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab. (2021) 33:2174&#x2013;88.e5. 10.1016/j.cmet.2021.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8443335</ArticleId><ArticleId IdType="pubmed">34599884</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. (2022) 13:3528. 10.1038/s41467-022-30836-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya JM, Rojas M, Salinas ML, Rodr&#xed;guez Y, Roa G, Lozano M, et al. Post-COVID syndrome. a case series and comprehensive review. Autoimmun Rev. (2021) 20:102947. 10.1016/j.autrev.2021.102947</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102947</ArticleId><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. (2020) 383:2255&#x2013;73. 10.1056/NEJMra2026131</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. (2021) 398:747&#x2013;58. 10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. (2021) 397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen A, Bressem K, Albrecht J, Thie&#xdf; HM, Vahldiek J, Hamm B, et al. The role of visceral adiposity in the severity of COVID-19: highlights from a unicenter cross-sectional pilot study in Germany. Metabolism. (2020) 110:154317. 10.1016/j.metabol.2020.154317</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154317</ArticleId><ArticleId IdType="pmc">PMC7358176</ArticleId><ArticleId IdType="pubmed">32673651</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhurandhar NV, Bailey D, Thomas D. Interaction of obesity and infections. Obes Rev. (2015) 16:1017&#x2013;29. 10.1111/obr.12320</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.12320</ArticleId><ArticleId IdType="pubmed">26354800</ArticleId></ArticleIdList></Reference><Reference><Citation>Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract. (2005) 69:29&#x2013;35. 10.1016/j.diabres.2004.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2004.11.007</ArticleId><ArticleId IdType="pubmed">15955385</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini E, Corsetti G, Romano C, Scarabelli TM, Chen-Scarabelli C, Saravolatz L, et al. Serum metabolic profile in patients with long-covid (PASC) syndrome: clinical implications. Front Med. (2021) 8:714426. 10.3389/fmed.2021.714426</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.714426</ArticleId><ArticleId IdType="pmc">PMC8339407</ArticleId><ArticleId IdType="pubmed">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Fogarty H, Dyer A, Martin-Loeches I, Bannan C, Nadarajan P, et al. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J Thromb Haemost. (2021) 19:1064&#x2013;70. 10.1111/jth.15267</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15267</ArticleId><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Prats-Uribe A, Feng Q, Wang Y, Gill D, Paredes R, et al. Clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19. JAMA Intern Med. (2022) 182:1063&#x2013;70. 10.1001/jamainternmed.2022.3858</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2022.3858</ArticleId><ArticleId IdType="pmc">PMC9389434</ArticleId><ArticleId IdType="pubmed">35980616</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardhana SA, Wolchok JD. The many faces of the anti-COVID immune response. J Exp Med. (2020) 17:e20200678. 10.1084/jem.20200678</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20200678</ArticleId><ArticleId IdType="pmc">PMC7191310</ArticleId><ArticleId IdType="pubmed">32353870</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckner FS, McCulloch DJ, Atluri V, Blain M, McGuffin SA, Nalla AK, et al. Clinical features and outcomes of 105 hospitalized patients with COVID-19 in Seattle, Washington. Clin Infect Dis. (2020) 71:2167&#x2013;73. 10.1093/cid/ciaa632</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa632</ArticleId><ArticleId IdType="pmc">PMC7314181</ArticleId><ArticleId IdType="pubmed">32444880</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. (2020) 55:2001217. 10.1183/13993003.01217-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01217-2020</ArticleId><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>de Rooij LPMH, Becker LM, Teuwen LA, Boeckx B, Jansen S, Feys S, et al. The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single cell resolution. Cardiovasc Res. (2022) cvac139. [Epub ahead of print]. 10.1093/cvr/cvac139</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac139</ArticleId><ArticleId IdType="pmc">PMC9452154</ArticleId><ArticleId IdType="pubmed">35998078</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacavalerie MR, Pierre-Francois S, Agossou M, Inamo J, Cabie A, Barnay JL, et al. Obese patients with long COVID-19 display abnormal hyperventilatory response and impaired gas exchange at peak exercise. Future Cardiol. (2022) 18:577&#x2013;84. 10.2217/fca-2022-0017</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fca-2022-0017</ArticleId><ArticleId IdType="pmc">PMC9169685</ArticleId><ArticleId IdType="pubmed">35658540</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med. (2020) 202:356&#x2013;60. 10.1164/rccm.202006-2157CP</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202006-2157CP</ArticleId><ArticleId IdType="pmc">PMC7397783</ArticleId><ArticleId IdType="pubmed">32539537</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobin MJ. Basing respiratory management of COVID-19 on physiological principles. Am J Respir Crit Care Med. (2020) 201:1319&#x2013;20. 10.1164/rccm.202004-1076ED</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202004-1076ED</ArticleId><ArticleId IdType="pmc">PMC7258630</ArticleId><ArticleId IdType="pubmed">32281885</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouffroy R, Jost D, Prunet B. Prehospital pulse oximetry: a red flag for early detection of silent hypoxemia in COVID-19 patients. Crit Care. (2020) 24:313. 10.1186/s13054-020-03036-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03036-9</ArticleId><ArticleId IdType="pmc">PMC7278215</ArticleId><ArticleId IdType="pubmed">32513249</ArticleId></ArticleIdList></Reference><Reference><Citation>Villarreal-Fernandez E, Patel R, Golamari R, Khalid M, DeWaters A, Haouzi P. A plea for avoiding systematic intubation in severely hypoxemic patients with COVID-19-associated respiratory failure. Crit Care. (2020) 24:337. 10.1186/s13054-020-03063-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03063-6</ArticleId><ArticleId IdType="pmc">PMC7291186</ArticleId><ArticleId IdType="pubmed">32532318</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Arab O, Huette P, Berna P, Mahjoub Y. Tracheal trauma after difficult airway management in morbidly obese patients with COVID-19. Br J Anaesth. (2020) 125:e168&#x2013;70. 10.1016/j.bja.2020.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7151281</ArticleId><ArticleId IdType="pubmed">32334809</ArticleId></ArticleIdList></Reference><Reference><Citation>Colla J, Rodos A, Seyller H, Weingart S. Fighting COVID-19 hypoxia with one hand tied behind our back: blanket prohibition of high-flow oxygen and noninvasive positive end-expiratory pressure in US hospitals. Ann Emerg Med. (2020) 75:791&#x2013;2. 10.1016/j.annemergmed.2020.04.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2020.04.015</ArticleId><ArticleId IdType="pmc">PMC7151538</ArticleId><ArticleId IdType="pubmed">32471585</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobler CC, Murad MH, Wilson ME. Noninvasive positive pressure ventilation in patients with COVID-19. Mayo Clin Proc. (2020) 95:2594&#x2013;601. 10.1016/j.mayocp.2020.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7543969</ArticleId><ArticleId IdType="pubmed">33276832</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobohm L, Sagoschen I, Barco S, Farmakis IT, Fedeli U, Koelmel S, et al. COVID-19 infection and its impact on case-fatality in patients with pulmonary embolism. Eur Respir J. (2022) [Epub ahead of print]. 10.1183/13993003.00619-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00619-2022</ArticleId><ArticleId IdType="pmc">PMC9411730</ArticleId><ArticleId IdType="pubmed">35981745</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers JD, Crichton ML, Goeminne PC, Cao B, Humbert M, Shteinberg M, et al. Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline. Eur Respir J. (2021) 57:2100048. 10.1183/13993003.00048-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00048-2021</ArticleId><ArticleId IdType="pmc">PMC7947358</ArticleId><ArticleId IdType="pubmed">33692120</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez K, Laffan M, Bradbury C. Debate: should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID-19 while we are awaiting the results of clinical trials? Br J Haematol. (2021) 192:459&#x2013;66. 10.1111/bjh.17241</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.17241</ArticleId><ArticleId IdType="pmc">PMC7753713</ArticleId><ArticleId IdType="pubmed">33236402</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow CS, Hasan SS. The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19. Rev Esp Cardiol. (2021) 74:114&#x2013;5. 10.1016/j.rec.2020.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2020.08.009</ArticleId><ArticleId IdType="pmc">PMC7455174</ArticleId><ArticleId IdType="pubmed">32933883</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro F, Nu&#xf1;ez-Gil IJ, Vitale E, Viana-Llamas MC, Reche-Martinez B, Romero-Pareja R, et al. Antiplatelet therapy and outcome in COVID-19: the health outcome predictive evaluation registry. Heart. (2022) 108:130&#x2013;6. 10.1136/heartjnl-2021-319552</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2021-319552</ArticleId><ArticleId IdType="pmc">PMC8494537</ArticleId><ArticleId IdType="pubmed">34611045</ArticleId></ArticleIdList></Reference><Reference><Citation>Attacc Investigators; Activ-4a Investigators; Remap-Cap Investigators Lawler PR, Goligher EC, Berger JS, et al. Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. N Engl J Med. (2021) 385:790&#x2013;802. 10.1056/NEJMoa2105911</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2105911</ArticleId><ArticleId IdType="pmc">PMC8362594</ArticleId><ArticleId IdType="pubmed">34351721</ArticleId></ArticleIdList></Reference><Reference><Citation>Sholzberg M, Tang GH, Rahhal H, AlHamzah M, Kreuziger LB, &#xc1;inle FN, et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. (2021) 375:n2400. 10.1136/bmj.n2400</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2400</ArticleId><ArticleId IdType="pmc">PMC8515466</ArticleId><ArticleId IdType="pubmed">34649864</ArticleId></ArticleIdList></Reference><Reference><Citation>Spyropoulos AC, Goldin M, Giannis D, Diab W, Wang J, Khanijo S, et al. Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial. JAMA Intern Med. (2021) 181:1612&#x2013;20. 10.1001/jamainternmed.2021.6203</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6203</ArticleId><ArticleId IdType="pmc">PMC8498934</ArticleId><ArticleId IdType="pubmed">34617959</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes RD, de Barros E, Silva PGM, Furtado RHM, Macedo AVS, Bronhara B, et al. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. Lancet. (2021) 397:2253&#x2013;63. 10.1016/S0140-6736(21)01203-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01203-4</ArticleId><ArticleId IdType="pmc">PMC8177770</ArticleId><ArticleId IdType="pubmed">34097856</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Paz L, Galli M, Capodanno D, Franchi F, Rollini F, Bikdeli B, et al. Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. (2022) 8:677&#x2013;86. 10.1093/ehjcvp/pvab070</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcvp/pvab070</ArticleId><ArticleId IdType="pmc">PMC8499924</ArticleId><ArticleId IdType="pubmed">34519777</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerotziafas GT, Catalano M, Colgan MP, Pecsvarady Z, Wautrecht JC, Fazeli B, et al. Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-European independent foundation in angiology/vascular medicine. Thromb Haemost. (2020) 120:1597&#x2013;628. 10.1055/s-0040-1715798</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1715798</ArticleId><ArticleId IdType="pmc">PMC7869052</ArticleId><ArticleId IdType="pubmed">32920811</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes GD, Burnett A, Allen A, Ansell J, Blumenstein M, Clark NP, et al. Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. (2022) 54:197&#x2013;210. 10.1007/s11239-022-02643-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-022-02643-3</ArticleId><ArticleId IdType="pmc">PMC9111941</ArticleId><ArticleId IdType="pubmed">35579732</ArticleId></ArticleIdList></Reference><Reference><Citation>Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, et al. Thromboprophylaxis in patients with COVID-19: a brief update to the CHEST guideline and expert panel report. Chest. (2022) 162:213&#x2013;25. 10.1016/j.chest.2022.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2022.02.006</ArticleId><ArticleId IdType="pmc">PMC8839802</ArticleId><ArticleId IdType="pubmed">35167861</ArticleId></ArticleIdList></Reference><Reference><Citation>Mussini C, Falcone M, Nozza S, Sagnelli C, Parrella R, Meschiari M, et al. Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT). Clin Microbiol Infect. (2021) 27:389&#x2013;95. 10.1016/j.cmi.2020.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.12.011</ArticleId><ArticleId IdType="pmc">PMC7833273</ArticleId><ArticleId IdType="pubmed">33359375</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors JM, Ridker PM. Antithrombotic prophylaxis for symptomatic outpatients with COVID-19: less is consistently more. Lancet Haematol. (2022) 9:e551&#x2013;3. 10.1016/S2352-3026(22)00205-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(22)00205-8</ArticleId><ArticleId IdType="pmc">PMC9243566</ArticleId><ArticleId IdType="pubmed">35779559</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. (2022) 399:1303&#x2013;12. 10.1016/S0140-6736(22)00462-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00462-7</ArticleId><ArticleId IdType="pmc">PMC8926413</ArticleId><ArticleId IdType="pubmed">35305296</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. (2022) 399:1618&#x2013;24. 10.1016/S0140-6736(22)00327-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00327-0</ArticleId><ArticleId IdType="pmc">PMC8989396</ArticleId><ArticleId IdType="pubmed">35397851</ArticleId></ArticleIdList></Reference><Reference><Citation>Who Rapid Evidence Appraisal for Covid-19 Therapies (React) Working Group, Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. (2020) 324:1330&#x2013;41. 10.1001/jama.2020.17023</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17023</ArticleId><ArticleId IdType="pmc">PMC7489434</ArticleId><ArticleId IdType="pubmed">32876694</ArticleId></ArticleIdList></Reference><Reference><Citation>Who Rapid Evidence Appraisal for Covid-19 Therapies (React) Working Group, Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. (2021) 384:693&#x2013;704. 10.1056/NEJMoa2021436</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. (2020) 324:1307&#x2013;16. 10.1001/jama.2020.17021</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17021</ArticleId><ArticleId IdType="pmc">PMC7489411</ArticleId><ArticleId IdType="pubmed">32876695</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health.
Coronavirus disease 2019 (COVID-19) treatment guidelines. (2021). Available online at: https://www.Covid19treatmentguidelines.Nih.Gov/
(accessed October 6, 2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R, et al. ESCMID COVID-19 living guidelines: drug treatment and clinical management. Clin Microbiol Infect. (2022) 28:222&#x2013;38. 10.1016/j.cmi.2021.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.007</ArticleId><ArticleId IdType="pmc">PMC8606314</ArticleId><ArticleId IdType="pubmed">34823008</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, et al. Infectious diseases society of america guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. (2020) ciaa478. [Epub ahead of print]. 10.1093/cid/ciaa478</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa478</ArticleId><ArticleId IdType="pmc">PMC7197612</ArticleId><ArticleId IdType="pubmed">32338708</ArticleId></ArticleIdList></Reference><Reference><Citation>Malgie J, Schoones JW, Pijls BG. Decreased mortality in coronavirus disease 2019 patients treated with tocilizumab: a rapid systematic review and meta-analysis of observational studies. Clin Infect Dis. (2021) 72:e742&#x2013;9. 10.1093/cid/ciaa1445</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1445</ArticleId><ArticleId IdType="pmc">PMC7543350</ArticleId><ArticleId IdType="pubmed">32964913</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeshima K, Yamaoka K, Kubo S, Nakano K, Iwata S, Saito K, et al. The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-&#x3b3; and interleukin-17 production by human CD4+ T cells. Arthritis Rheum. (2012) 64:1790&#x2013;8. 10.1002/art.34329</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34329</ArticleId><ArticleId IdType="pubmed">22147632</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaka AS, MacDonald R, Greer N, Vela K, Duan-Porter W, Obley A, et al. Major update: remdesivir for adults with COVID-19 : a living systematic review and meta-analysis for the American College of Physicians Practice Points. Ann Intern Med. (2021) 174:663&#x2013;72. 10.7326/M20-8148</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-8148</ArticleId><ArticleId IdType="pmc">PMC7901604</ArticleId><ArticleId IdType="pubmed">33560863</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XJ, Qin JJ, Cheng X, Shen L, Zhao YC, Yuan Y, et al. In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19. Cell Metab. (2020) 32:176&#x2013;87.e4. 10.1016/j.cmet.2020.06.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.06.015</ArticleId><ArticleId IdType="pmc">PMC7311917</ArticleId><ArticleId IdType="pubmed">32592657</ArticleId></ArticleIdList></Reference><Reference><Citation>Remap-Cap Investigators, Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, et al. Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N Engl J Med. (2021) 384:1491&#x2013;502. 10.1056/NEJMoa2100433</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2100433</ArticleId><ArticleId IdType="pmc">PMC7953461</ArticleId><ArticleId IdType="pubmed">33631065</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. (2020) 28:1195&#x2013;9. 10.1002/oby.22831</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.22831</ArticleId><ArticleId IdType="pmc">PMC7262326</ArticleId><ArticleId IdType="pubmed">32271993</ArticleId></ArticleIdList></Reference><Reference><Citation>Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, et al. Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission. Clin Infect Dis. (2020) 71:896&#x2013;7. 10.1093/cid/ciaa415</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa415</ArticleId><ArticleId IdType="pmc">PMC7184372</ArticleId><ArticleId IdType="pubmed">32271368</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q, et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. (2020) 43:1392&#x2013;8. 10.2337/dc20-0576</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-0576</ArticleId><ArticleId IdType="pubmed">32409502</ArticleId></ArticleIdList></Reference><Reference><Citation>Kass DA, Duggal P, Cingolani O. Obesity could shift severe COVID-19 disease to younger ages. Lancet. (2020) 395:1544&#x2013;5. 10.1016/S0140-6736(20)31024-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31024-2</ArticleId><ArticleId IdType="pmc">PMC7196905</ArticleId><ArticleId IdType="pubmed">32380044</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in critically ill patients in the Seattle Region - case series. N Engl J Med. (2020) 382:2012&#x2013;22. 10.1056/NEJMoa2004500</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2004500</ArticleId><ArticleId IdType="pmc">PMC7143164</ArticleId><ArticleId IdType="pubmed">32227758</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli CM, Jones SA, Yang J, Rajagopalan H, O&#x2019;Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. (2020) 369:m1966. 10.1136/bmj.m1966</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1966</ArticleId><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of Covid-19 in New York city. N Engl J Med. (2020) 382:2372&#x2013;4. 10.1056/NEJMc2010419</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2010419</ArticleId><ArticleId IdType="pmc">PMC7182018</ArticleId><ArticleId IdType="pubmed">32302078</ArticleId></ArticleIdList></Reference><Reference><Citation>Tartof SY, Qian L, Hong V, Wei R, Nadjafi RF, Fischer H, et al. Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization. Ann Intern Med. (2020) 173:773&#x2013;81. 10.7326/M20-3742</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-3742</ArticleId><ArticleId IdType="pmc">PMC7429998</ArticleId><ArticleId IdType="pubmed">32783686</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>